Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting

References

• Hex N Bartlett C Wright D Taylor M Varley D Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs Diabet Med 2012 29 7 855 862 22537247
   PubMed Web of Science ®Google Scholar
• Fonseca VA Defining and characterizing the progression of type 2 diabetes Diabetes Care 2009 32 Suppl 2 S151 S156 19875543
   PubMed Web of Science ®Google Scholar
• Shaw JE Sicree RA Zimmet PZ Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res Clin Pract 2010 87 1 4 14 19896746
   PubMed Web of Science ®Google Scholar
• Adibe MO Aguwa CN Ukwe CV Cost-utility analysis of pharmaceutical care intervention versus usual care in management of Nigerian patients with type 2 diabetes Value in Health Regional Issues 2013 2 2 189 198
   Google Scholar
• worldbankorg [homepage on the Internet] World DataBank: World development indicators The World Bank 2014 [cited December 26, 2013]. Available from: http://databank.worldbank.org/data/views/variableselection/selectvariables.aspx?source=world-development-indicators#s_p Accessed. March 26, 2014
   Google Scholar
• Buse JB Ginsberg HN Bakris GL American Heart Association; American Diabetes Association Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association Diabetes Care 2007 30 1 162 172 17192355
   PubMed Web of Science ®Google Scholar
• Morrish NJ Wang SL Stevens LK Fuller JH Keen H Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes Diabetologia 2001 44 Suppl 2 S14 S21 11587045
   PubMed Web of Science ®Google Scholar
• McLarty DG Swai AB Kitange HM Prevalence of diabetes and impaired glucose tolerance in rural Tanzania Lancet 1989 1 8643 871 875 2564951
   PubMed Web of Science ®Google Scholar
• Rodbard HW Blonde L Braithwaite SS AACE Diabetes Mellitus Clinical Practice Guidelines Task Force American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus Endocr Pract 2007 13 Suppl 1 S1 S68
   PubMedGoogle Scholar
• Bellamy L Casas JP Hingorani AD Williams D Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis Lancet 2009 373 9677 1773 1779 19465232
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Standards of medical care in diabetes – 2012 Diabetes Care 2012 35 Suppl 1 S11 S63 22187469
   PubMed Web of Science ®Google Scholar
• Schienkiewitz A Schulze MB Hoffmann K Kroke A Boeing H Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Am J Clin Nutr 2006 84 2 427 433 16895894
   PubMed Web of Science ®Google Scholar
• Jeon CY Lokken RP Hu FB van Dam RM Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review Diabetes Care 2007 30 3 744 752 17327354
   PubMed Web of Science ®Google Scholar
• Inzucchi SE Bergenstal RM Buse JB American Diabetes Association (ADA) European Association for the Study of Diabetes (EASD) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 2012 35 6 1364 1379 22517736
   PubMed Web of Science ®Google Scholar
• Funnell MM Brown TL Childs BP National standards for diabetes self-management education Diabetes Care 2012 35 Suppl 1 S101 S108 22187467
   PubMed Web of Science ®Google Scholar
• Norris SL Lau J Smith SJ Schmid CH Engelgau MM Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control Diabetes Care 2002 25 7 1159 1171 12087014
   PubMed Web of Science ®Google Scholar
• Davies MJ Heller S Skinner TC Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial BMJ 2008 336 7642 491 495 18276664
   PubMed Web of Science ®Google Scholar
• Jennings A Mead A Jones J Holden A Connolly S Preventive Cardiology: A Practical Manual Oxford Oxford University Press 2009
   Google Scholar
• American Diabetes Association Gestational diabetes mellitus Diabetes Care 2004 27 Suppl 1 S88 S90 14693936
   PubMed Web of Science ®Google Scholar
• Tuomilehto J Lindström J Eriksson JG Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 2001 344 18 1343 1350 11333990
   PubMed Web of Science ®Google Scholar
• Ramachandran A Snehalatha C Mary S Mukesh B Bhaskar AD Vijay V Indian Diabetes Prevention Programme (IDPP) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia 2006 49 2 289 297 16391903
   PubMed Web of Science ®Google Scholar
• Knowler WC Barrett-Connor E Fowler SE Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 2002 346 6 393 403 11832527
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research Group; Knowler WC Fowler SE Hamman RF 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Lancet 2009 374 9702 1677 1686 19878986
   PubMed Web of Science ®Google Scholar
• Chatterton H Younger T Fischer A Khunti K Programme Development Group Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance BMJ 2012 345 e4624 22791792
   PubMed Web of Science ®Google Scholar
• Hamman RF Wing RR Edelstein SL Effect of weight loss with lifestyle intervention on risk of diabetes Diabetes Care 2006 29 9 2102 2107 16936160
   PubMed Web of Science ®Google Scholar
• Look AHEAD Research Group; Wing RR Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial Arch Intern Med 2010 170 17 1566 1575 20876408
   PubMedGoogle Scholar
• Wing RR Bolin P Brancati FL Look AHEAD Research Group Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes N Engl J Med 2013 369 2 145 154 23796131
   PubMed Web of Science ®Google Scholar
• Franz MJ The dilemma of weight loss in diabetes Diabetes Spectr 2007 20 3 133 136
   Google Scholar
• Diabetes Prevention Program Research Group Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes Diabetes Care 2003 26 9 2518 2523 12941712
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE) Preventing Type 2 Diabetes – Risk Identification and Interventions for Individuals at High Risk (PH38) London National Institute for Health and Care Excellence 2012 Available from: http://guidance.nice.org.uk/PH38 Accessed March 26, 2014
   Google Scholar
• Brooks NA Type 2 diabetes: lifestyle changes and drug treatment Virtual Mentor 2009 11 3 237 241 23194906
   PubMedGoogle Scholar
• Stratton IM Adler AI Neil HA Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 2000 321 7258 405 412 10938048
   PubMed Web of Science ®Google Scholar
• Dormandy JA Charbonnel B Eckland DJ PROactive investigators Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 2005 366 9493 1279 1289 16214598
   PubMed Web of Science ®Google Scholar
• Singh S Loke YK Furberg CD Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis JAMA 2007 298 10 1189 1195 17848653
   PubMed Web of Science ®Google Scholar
• Rubin RR Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus Am J Med 2005 118 Suppl 5A 27S 34S 15850551
   PubMed Web of Science ®Google Scholar
• Harrison LB Adams-Huet B Raskin P Lingvay I β-cell function preservation after 3.5 years of intensive diabetes therapy Diabetes Care 2012 35 7 1406 1412 22723578
   PubMed Web of Science ®Google Scholar
• Holman RR Paul SK Bethel MA Matthews DR Neil HA 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 2008 359 15 1577 1589 18784090
   PubMed Web of Science ®Google Scholar
• ADVANCE Collaborative Group; Patel A MacMahon S Chalmers J Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 2008 358 24 2560 2572 18539916
   PubMed Web of Science ®Google Scholar
• Gerstein HC Miller ME Genuth S ACCORD Study Group Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 2011 364 9 818 828 21366473
   PubMed Web of Science ®Google Scholar
• Duckworth W Abraira C Moritz T VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 2009 360 2 129 139 19092145
   PubMed Web of Science ®Google Scholar
• Mooradian AD Chehade JM Diabetes mellitus in older adults Am J Ther 2012 19 2 145 159 21248617
   PubMed Web of Science ®Google Scholar
• Wright A Burden AC Paisey RB Cull CA Holman RR UK Prospective Diabetes Study Group Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57) Diabetes Care 2002 25 2 330 336 11815505
   PubMed Web of Science ®Google Scholar
• Schwartz AV Sellmeyer DE Vittinghoff E Thiazolidinedione use and bone loss in older diabetic adults J Clin Endocrinol Metab 2006 91 9 3349 3354 16608888
   PubMed Web of Science ®Google Scholar
• Hillaire-Buys D Faillie JL Montastruc JL Pioglitazone and bladder cancer Lancet 2011 378 9802 1543 1544 22035550
   PubMed Web of Science ®Google Scholar
• Kim W Egan JM The role of incretins in glucose homeostasis and diabetes treatment Pharmacol Rev 2008 60 4 470 512 19074620
   PubMed Web of Science ®Google Scholar
• Nyenwe EA Jerkins TW Umpierrez GE Kitabchi AE Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes Metabolism 2011 60 1 1 23 21134520
   PubMed Web of Science ®Google Scholar
• Goodarzi MO Bryer-Ash M Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents Diabetes Obes Metab 2005 7 6 654 665 16219009
   PubMed Web of Science ®Google Scholar
• Hirst JA Farmer AJ Ali R Roberts NW Stevens RJ Quantifying the effect of metformin treatment and dose on glycemic control Diabetes Care 2012 35 2 446 454 22275444
   PubMed Web of Science ®Google Scholar
• Marso SP Kennedy KF House JA McGuire DK The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis Diab Vasc Dis Res 2010 7 2 119 130 20382775
   PubMed Web of Science ®Google Scholar
• Pedersen O Gaede P Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study Metabolism 2003 52 8 Suppl 1 19 23 12939735
   PubMed Web of Science ®Google Scholar
• Gaede P Lund-Andersen H Parving HH Pedersen O Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 2008 358 6 580 591 18256393
   PubMed Web of Science ®Google Scholar
• Kearney PM Blackwell L Collins R Cholesterol Treatment Trialists’ (CTT) Collaborators Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis Lancet 2008 371 9607 117 125 18191683
   PubMed Web of Science ®Google Scholar
• Stone NJ Robinson J Lichtenstein AH 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atheroscle-rotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation Epub 11 7 2013
   Google Scholar
• Perk J De Backer G Gohlke H European Association for Cardiovascular Prevention and Rehabilitation (EACPR) ESC Committee for Practice Guidelines (CPG) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur Heart J 2012 33 13 1635 1701 22555213
   PubMed Web of Science ®Google Scholar
• Chinenye S Ofoegbu EN Onyemelukwe GC Uloko AE Ogbera AO Clinical Practice Guidelines for Diabetes Management in Nigeria 2nd edition Port Harcourt Diabetes Association of Nigeria 2013
   Google Scholar
• Chinenye S Ogbera AO Socio-cultural aspects of diabetes mellitus in Nigeria J Soc Health Diabetes 2013 1 1 15 21
   Google Scholar
• Uloko AE Obegbu EN Chinenye S Profile of Nigerians with diabetes mellitus – Diabcare Nigeria study group (2008): Results of a multicenter study Indian J Endocrinol Metab 2012 16 4 558 564 22837916
   PubMedGoogle Scholar
• Nwankwo CH Nandy B Nwankwo BO Factors influencing diabetes management outcome among patients attending government health facilities in South East Nigeria International Journal of Tropical Medicine 2010 5 2 28 36
   Google Scholar
• Willover S Apply holistic care collaboration to type 2 diabetes Managed Healthcare Executive [serial on the Internet] 11 1 2013 [cited March 4, 2014] 1 4 Available from: http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/apply-holistic-care-collaboration-type-2-diabetes Accessed March 26, 2014
   Google Scholar
• Stock S Drabik A Büscher G German diabetes management programs improve quality of care and curb costs Health Aff (Millwood) 2010 29 12 2197 2205 21134920
   PubMed Web of Science ®Google Scholar
• Ogbera AO Dada O Adeyeye F Jewo PI Complementary and alternative medicine use in diabetes mellitus West Afr J Med 2010 29 3 158 162 20665458
   PubMedGoogle Scholar
• Rydén L Standl E Bartnik M Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) European Association for the Study of Diabetes (EASD) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 2007 28 1 88 136 17220161
   PubMed Web of Science ®Google Scholar